WPRIM Management System> DCMS> Journal of International Oncology> 2012> 39> 3

Volume: 39 Issue: 3

1. BRAFV600E gene mutation in papillary thyroid cancer Page:206—208
2. Biological function of Securin and prospect for research in tumor Page:176—179
3. EZH2 gene and cancer Page:182—186
4. Advance of the targeted anti-tumor drugs with small molecule compounds Page:172—175
5. Molecular mechanism of cisplatin resistance in ovarian cancer Page:234—236
6. Helicobacter pylori and colorectal cancer Page:228—230
7. Treatment of hepatocellular carcinoma with portal vein tumor thrombus Page:225—227
8. Mammalian target of rapamycin in gastric cancer Page:222—224
9. Application of epidermal growth factor receptor for radiotherapy of esophageal cancer Page:218—220
10. EMLA-ALK fusion gene in non-small cell lung cancer Page:212—214
11. Therapy of triple negative breast cancer Page:209—211
12. Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma Page:200—202
13. Radiosensitizing effect of natural active product on tumor Page:196—200
14. Gene targeting diagnosis and treatment in cancer Page:186—189
15. Mechanism of polarity proteins regulate tumorigenesis Page:179—182
16. Function and advance of GPR30 in hormone-related neoplasms Page:166—169
17. Diagnostic application value of urothelial carcinoma of the urinary bladder by dual color fluorescence in-situ hybridization Page:237—240
18. Progress of the angiogenesis correlation factors for endometrial carcinoma Page:230—233
19. HMGB1 and gastric cancer Page:220—222
20. Different fractionations of radiotherapy in non-small cell lung cancer Page:215—217
21. Variety of molecular mechanisms of cisplatin in the treatment of nasopharyngeal carcinoma Page:203—205
22. Application of nanoparticle vectors in photodynamic therapy of tumors Page:193—196
23. Antiangiogenic therapy for PTCL Page:190—193
24. Advances of tumor-associated fibroblasts in carcinogenesis Page:163—166
25. Aminopeptidase N and its inhibitors and carcinoma Page:169—171,233